Optimistic, but for how long? Our big takeaways from #JPM2024

FromBioSpace

Start listening View podcast show

Optimistic, but for how long? Our big takeaways from #JPM2024

FromBioSpace

ratings:

Length:

14 minutes

Released:

Jan 17, 2024

Format:

Podcast episode

Description

The team comes together to discuss the dominant themes of what was an incredibly busy week of events in San Francisco.
There was an air of hope and optimism concerning biopharma funding - but will it last?
Lori Ellis, Greg Slabodkin and Tyler Patchen discuss.

Released:

Jan 17, 2024

Format:

Podcast episode

Titles in the series (46)

Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.

Skip carousel

Q3 earnings recap: winners, losers & surprises by BioSpace
18 min listen
Zepbound vs Wegovy: a two horse race by BioSpace
14 min listen
Artificial Intelligence, Part 1: Bias, Access, ROI, Potential Success and Failure by BioSpace
18 min listen
Integrating AI in life sciences to change employee behavior with Microsoft and IQVIA by BioSpace
21 min listen
Artificial Intelligence, Part 2: Human Interaction, Liability, and Patient Safety by BioSpace
17 min listen
Deals, Dupixent and GLP-1 drug shortages by BioSpace
17 min listen
The top life sciences startups to watch this year by BioSpace
15 min listen
Fast and furious evolution: how to ensure AI is catalyst for positive societal change with Microsoft and IQVIA by BioSpace
32 min listen
First ever CRISPR gene therapy approval: What happens next? by BioSpace
13 min listen
GLP-1 and ADC rollercoasters pick up speed by BioSpace
13 min listen
Artificial Intelligence, Part 3: Improving Communication to Impact Patient Behavior by BioSpace
17 min listen
What VCs look for when investing with MPM Capital, Endeavor Venture Fund and Two Bear Capital by BioSpace
45 min listen
Major FDA approvals for Vertex/CRISPR; bluebird gets black box warning and price scrutiny by BioSpace
17 min listen
On the ground at #JPM2024 - Day 3 highlights by BioSpace
12 min listen
Alternative funding strategies to discuss at JPM with Halia Therapeutics, the ADDF and Triumvira Immunologics by BioSpace
48 min listen
What VCs really think of the market right now with MPM Capital, Endeavor Venture Fund and Two Bear Capital by BioSpace
22 min listen
On the ground at #JPM2024 - Day 2 highlights by BioSpace
12 min listen
Grab an umbrella, it's raining ⁠IPOs⁠! by BioSpace
11 min listen
Optimistic, but for how long? Our big takeaways from #JPM2024 by BioSpace
14 min listen
Every move you make: biopharma industry under heavy scrutiny by BioSpace
16 min listen
On the ground at #JPM2024 - Day 1 highlights by BioSpace
10 min listen
Iovance wins with Amtagvi and the ADC train chugs on by BioSpace
14 min listen
What can biopharma expect from the job market? by BioSpace
18 min listen
Did WuXi Make a Whoopsie? US-China R&D Relations in Limbo by BioSpace
12 min listen
Keep calm and CAR-T on? by BioSpace
18 min listen
Sweet succession: Gonzalez, patent thickets and his triumph over biosimilars by BioSpace
14 min listen
Eyes on the prize: Novo buys Catalent by BioSpace
29 min listen
Historic approval for MASH, CAR-Ts in the spotlight by BioSpace
18 min listen
The skinny on weight loss, donanemab and the State of the Union by BioSpace
16 min listen
The ABCs of ADCs: Why antibody-drug conjugates are so hot right now by BioSpace
11 min listen

More Episodes from BioSpace

Skip carousel

Bayer Layoffs, a Big Alzheimer’s Deal and ASGCT Wrap by BioSpace
15 min listen
Women's Health: Where Politics and Science Meet by BioSpace
22 min listen
ASGCT, Adcomm for Lilly’s Donanemab, Vertex Vs. Bluebird by BioSpace
12 min listen
BioSpace Heads to #ASGCT, Along with Thousands in Cell and Gene Therapy by BioSpace
12 min listen
The IRA, BMS’ Big Cuts, First WHIM Approval by BioSpace
16 min listen
Where Do We Go From Here? The Future of Women's Health by BioSpace
22 min listen
Sanofi Layoffs, CAR-T Warnings and a New GLP-1 Player by BioSpace
18 min listen
Amylyx and ALS, Continued ADC Excitement, Dire Drug Shortages by BioSpace
20 min listen
It's a Design Problem: Women and Clinical Trials by BioSpace
20 min listen
Alphabet Soup: AACR and ACC Dominate Headlines This Week by BioSpace
17 min listen
Did WuXi Make a Whoopsie? US-China R&D Relations in Limbo by BioSpace
12 min listen
Will the IRA’s Focus on the Pharmaceutical Industry Hurt the World’s Healthcare System Instead of Helping Patients? by BioSpace
22 min listen
Bayer’s sweeping executive cuts, Wegovy’s expanding reach by BioSpace
17 min listen
Money talk: Salary trends and raises by BioSpace
15 min listen
Historic approval for MASH, CAR-Ts in the spotlight by BioSpace
18 min listen
The unintended consequences of small molecules by BioSpace
25 min listen
The skinny on weight loss, donanemab and the State of the Union by BioSpace
16 min listen
The ABCs of ADCs: Why antibody-drug conjugates are so hot right now by BioSpace
11 min listen
The gap is where the pain is: Drug pricing and patient costs by BioSpace
20 min listen
Sweet succession: Gonzalez, patent thickets and his triumph over biosimilars by BioSpace
14 min listen
Iovance wins with Amtagvi and the ADC train chugs on by BioSpace
14 min listen
Eyes on the prize: Novo buys Catalent by BioSpace
29 min listen
Balancing act: Patient access and innovation by BioSpace
21 min listen
Keep calm and CAR-T on? by BioSpace
18 min listen
What can biopharma expect from the job market? by BioSpace
18 min listen
Grab an umbrella, it's raining ⁠IPOs⁠! by BioSpace
11 min listen
On the ground at #JPM2024 - Day 3 highlights by BioSpace
12 min listen
On the ground at #JPM2024 - Day 2 highlights by BioSpace
12 min listen
On the ground at #JPM2024 - Day 1 highlights by BioSpace
10 min listen
Alternative funding strategies to discuss at JPM with Halia Therapeutics, the ADDF and Triumvira Immunologics by BioSpace
48 min listen

Related podcast episodes

Skip carousel

171. Kizzmekia Corbett-Helaire & Francis Collins | Live from Faith and Science 2024: Francis Collins and Kizzmekia Corbett-Helaire are both renowned scientists and both of them played special and important roles during the pandemic. In this conversation, the two of them remember some of the key moments in the scientific development o... by Language of God
76 min listen
Cultural Update: Trends in Teenage Sex; Slogans in Israel/Palestine Conflict; Gender Affirming Care for Children; Listener Questions by Think Biblically: Conversations on Faith & Culture
57 min listen
Pediatrics Research Roundup, Surviving and Preparing for Disasters – Ep. 194: In this episode Rachel Moon, MD, FAAP, associate editor of digital media for the journal Pediatrics, shares a research roundup from the March issue. Hosts David Hill, MD, FAAP, and Joanna Parga-Belinkie, MD, FAAP, also talk to Felicitas Livaudais, MD,... by Pediatrics On Call
41 min listen
144. Francis Collins & Deb Liu | Live from Silicon Valley by Language of God
53 min listen
Episode 33: The Fiscal Cliff, The End Times & 2013 Predictions: In this week's Phil Vischer Podcast, Phil, Skye and Christian discuss the fiscal cliff and the current political environment in the US. This leads to a conversation about the end times and interpreting the Scriptures based on our cultural context.... by The Holy Post
48 min listen
Are We There Yet? When to Expect a COVID Vaccine by Skimm This
26 min listen
74. Francis Collins & David Anderson | How Christians Can End the Pandemic: Polling data tells us Christians are the most hesitant group in the United States about receiving the COVID-19 vaccines. Yet research on the vaccines show that they are incredibly safe and effective. It’s clear that if we want to get past this pandemic, ... by Language of God
55 min listen
E:80 How Science Proves God’s Existence: Were Adam and Eve real people? Was there a global flood? What about evolution? What’s the deal with Galileo? Is there scientific evidence to support the Incarnation of Jesus Christ? Today in this fascinating episode, I sit down with Fr. Robert Spitzer S.J., PH.D. to explore these questions and to unravel the common misconceptions that faith and science are opposed to each other and that the Catholic Church is anti-science. Fr. Spitzer also shares what he thinks are the 4 strongest evidences to prove God is real, and breaks down how can you understand the Trinity. by The Lila Rose Podcast
107 min listen
Elizabeth Harman & The Ethics of Abortion by The Philosopher & The News
75 min listen
BGN Radio #217: Eagles-Chiefs takeaways + Eagles-Panthers preview by Bleeding Green Nation: for Philadelphia Eagles fans
83 min listen
Baker’s Dozen: Philippinedization and Middle Power Security: In this podcast dedicated to the larger concepts of geopolitics, host Rodger Baker, Senior Vice President for Strategic analysis at RANE, explores the concept of Philippinedization. His guests are Dr. Chester B. Cabalza, Joshua Bernard B. Espeña, and... by RANE Podcast Series
30 min listen
Episode 348 IronRadio - Topic News, Mail, Explosive Lifts by Iron Radio
20 min listen
I’m a Panentheist and So Can You! - With Philip Clayton: This week Philip Clayton joins the podcast to discuss the wonders of Panentheism. Panentheism has played a major role in the faith journies of both of us and we wanted to share it with you. Enjoy! Resources: EcoCiv.org In Whom We Live and Move and H... by Rethinking Faith
63 min listen
TheESP - Ep. #207 - Coronavirus Misinformation: This week we first get the record straight and co… by The European Skeptics Podcast - The ESP
67 min listen
Rebalancing Literacy in the US - What Nonprofits Need to Do Now... (news): Nonprofitnewsfeed.com Fight Over Phonics Forces Curricula Revisions In Number Of U.S. Schools Lucy Calkins, an education professor and creator of the popular “Units of Study” curriculum used by a quarter of U.S. elementary schools, has significantl... by Using the Whole Whale - A Nonprofit Podcast
26 min listen
Rebalancing Literacy in the US – What Nonprofits Need to Do Now… (news): Nonprofitnewsfeed.com Fight Over Phonics Forces Curricula Revisions In Number Of U.S. Schools Lucy Calkins, an education professor and creator of the popular “Units of Study” curriculum used by a quarter of U.S. elementary schools, by Nonprofit News Feed Podcast
26 min listen
Your Vaccine Questions Answered: Why are shots still hard to find? What if your kid's had COVID already? Any side effects to look out for? We answer questions about COVID vaccines for young kids. by Consider This from NPR
13 min listen
Reaching Students Through a Holy Land Experience with Scott Phillips by Missions Today
26 min listen
20. Rick Lindroth | Hope in a World of Wounds: The question of faith and science has often been posed in only one direction—how does faith affect science? As Christians, this question is more comfortable because it plants our religious beliefs in the center, keeping them untouched. But what about whe... by Language of God
45 min listen
Kavanaugh and Climate Change (with Elise Larsen): We discuss Kavanaugh's possible confirmation and talk Hurricane Florence and climate change with guest Elise Larsen. by Pantsuit Politics
58 min listen
Chris & Nick Show: Bears preview, a tale of similar teams: Nick Falato and Chris Pflum discuss the Giants' week four opponent, the Chicago Bears. Both teams are surprisingly 2-1, and the podcasters talk about the key aspects that could lead each team to a victory. by Big Blue View: for New York Giants fans
25 min listen
Parents and Kids Are Ready for a Vaxxed Holiday: It's been a little more than two weeks since the Pfizer vaccine was approved for 5-11 year olds. by City Cast Chicago
16 min listen
Ep 332: Responsibility, Regulation, & Rocco the Parrot: Should social media companies be held responsible for the harm users inflict on their platforms? What about pharmaceutical companies marketing opioids? And gun manufacturers? Phil, Skye, and Christian get into a lively discussion about regulation and... by The Holy Post
42 min listen
Is Childfree the Way to Be? (with Gina Tomaine, Health and Wellness Editor for Philly Mag) by ShrinkChicks
48 min listen
168. The Sacred Chain | The Challenge of the Bible: The science of evolution has caused friction for many Christians. And science does pose some challenges to the way people have been taught to think about their faith, but those challenges don’t have to lead to a decision to reject faith—or to reject ... by Language of God
44 min listen
Reviews and Resources - September 2020 by The London Lyceum
11 min listen
Serve and Return: Supporting the Foundation: What is "serve and return"? What does it mean to have a "responsive relationship" with a child? How do responsive relationships support healthy brain development? And what can parents and caregivers do in their day-to-day lives to build these sorts of ... by The Brain Architects
27 min listen
Our Best Episode Ever: Self-promotion: the idea makes some people cringe and others salivate. In this episode, we talk about self-promotion in academic science. What amount - and maybe more importantly, what kind - is right? Why do some people shy away from it while others div... by The Black Goat
65 min listen
David Krakauer on Emergent Political Economies and A Science of Possibility (EPE 01) by COMPLEXITY: Physics of Life
53 min listen
Episode 367: Resilient Faith in Digital Babylon with David Kinnaman (Part 1): According to years of research from the Barna Group, only about 10% of young adults raised in the church have a resilient faith. Some may see that as bad news, but not David Kinnaman. He dug deeper to see what was different about these 4 million... by The Holy Post
67 min listen

Discover this podcast and so much more

Optimistic, but for how long? Our big takeaways from #JPM2024

Optimistic, but for how long? Our big takeaways from #JPM2024

Description

Titles in the series (46)

More Episodes from BioSpace

Related podcast episodes